Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $111.27 +0.32%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.03, $0.11 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.62 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
